Skip to main navigation
Skip to content
Opiant_logo Opiant
Main Menu
  • Contact
  • Careers
  • About
    • Corporate Overview
    • Management Team
    • Board of Directors
    • Medical Advisory Board
    • Media
    • Careers
  • Addiction Disorders
    • Opioid Use Disorder
    • Alcohol Use Disorder
    • Acute Cannabinoid Overdose
    • Patients & Families
    • Scientific Publications
  • Products & Pipeline
    • Pipeline Chart
  • Investors
    • Stock Information
      • Stock Quote & Chart
      • Historical Price Lookup
      • Investment Calculator
      • Analyst Coverage
    • News Releases
    • Events and Presentations
    • Corporate Governance
      • Board of Directors
      • Board Committees
      • Governance Documents
    • Financials & Filings
      • SEC Filings
      • Annual Reports & Proxy Statements

Investors

SEC Filing Details

SEC Filing Details

Document Details

Form
4/A
Filing Date
Jul 13, 2020
Document Date
Jul 10, 2020
Form Description
Amendment to a previously filed 4
Filing Group
3,4,5
Company
Opiant Pharmaceuticals, Inc.
Issuer
Opiant Pharmaceuticals, Inc.
Filer
Sinclair Michael

Filing Formats

View HTML
Download PDF
Download DOC
Download XLS
Print Page
RSS Feeds
Email Alerts
Contact IR

  • Privacy Policy
  • Site Map
© Opiant, 2021. All Rights Reserved.